Nine of the 74 bosentan-treated patients who had elevated liver aminotransferases (> 3 × ULN) also had symptoms such as abdominal pain, nausea/vomiting, and fever.
Üheksal 74- st bosentaanravi saanud patsiendist, kellel ilmnes maksa aminotransferaaside aktiivsuse tõus (> 3 × ULN), ilmnesid ka sellised sümptomid nagu kõhuvalu, iiveldus/ oksendamine ja palavik.